Biohaven Ltd. - stock earnings
BHVN Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -102.6 million USD | ? USD |
| 2023Q2 | -90.3 million USD | ? USD |
| 2023Q1 | -70.5 million USD | ? USD |
| 2022Q4 | -201.1 million USD | -215.1 million USD |
| 2022Q3 | -68.9 million USD | ? USD |
| 2022Q2 | -203.3 million USD | 215.1 million USD |
| 2022Q1 | -97.0 million USD | 318.9 million USD |
| 2021Q4 | -51.9 million USD | 190.0 million USD |
| 2021Q3 | -54.4 million USD | 135.7 million USD |
| 2021Q2 | -210.6 million USD | 92.9 million USD |
| 2021Q1 | -265.0 million USD | 43.8 million USD |
| 2020Q4 | -217.7 million USD | 35.1 million USD |
| 2020Q3 | -195.2 million USD | 17.7 million USD |
| 2020Q2 | -180.9 million USD | 9.7 million USD |
| 2020Q1 | -172.9 million USD | 1.2 million USD |
| 2019Q3 | -106.2 million USD | ? USD |
| 2019Q2 | -211.1 million USD | ? USD |
| 2019Q1 | -62.3 million USD | ? USD |
| 2018Q3 | -61.4 million USD | ? USD |
| 2018Q2 | -39.3 million USD | ? USD |
| 2018Q1 | -85.5 million USD | ? USD |
| 2017Q3 | -42.9 million USD | ? USD |
| 2017Q2 | -38.4 million USD | ? USD |
| 2017Q1 | -18.8 million USD | ? USD |
BHVN Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -570.3 million USD | ? USD |
| 2021 | -213.8 million USD | 462.5 million USD |
| 2020 | -118.7 million USD | ? USD |
| 2019 | -528.8 million USD | ? USD |
| 2018 | -240.9 million USD | ? USD |
| 2017 | -139.2 million USD | ? USD |
BHVN
Price: $40.69
52 week price:
Earnings Per Share: -5.73 USD
P/E Ratio: -6.15
Exchange: NYQ
Sector: Healthcare
Industry: Biotechnology
Volume: 704100
Ebitda: -42.6 millionMarket Capitalization: 4.3 billion